#$%^&*AU2019261786A120200528.pdf#####Abstract The invention provides a suspension concentrate formulation which includes more than 400 g/litre of a suitable active ingredient or of a combination of suitable active ingredients； an anionic dispersant； a polymeric stabiliser； a rheology modifier； and 5 water. Examples of active ingredient are iprodione, methoxyfenozide, propyzamide, tebuconazole, azoxystrobin and a combination of tebuconazole and azoxystrobin. 10 The invention also provides methods for determining whether a selected active ingredient is suitable for formulation as an aqueous suspension concentrate. 15 24
